Colon disease targets and uses thereof
AssigneeCelera Corporation
InventorsYeounjin Kim, Tao He, Steve Ruben
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
Claims3
A method of diagnosing colon cancer in an individual, the method comprising detecting an elevated level of CD-MPR protein in a colon sample from the individual relative to a control CD-MPR protein level of a non-cancerous colon sample, wherein the elevated level of CD-MPR protein indicates that the individual has colon cancer, and wherein the amino acid sequence of the CD-MPR protein comprises SEQ ID NO:205.
Dependencies are inferred from the claim text.